205 related articles for article (PubMed ID: 20677943)
21. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.
Dolganiuc A; Oak S; Kodys K; Golenbock DT; Finberg RW; Kurt-Jones E; Szabo G
Gastroenterology; 2004 Nov; 127(5):1513-24. PubMed ID: 15521019
[TBL] [Abstract][Full Text] [Related]
22. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
23. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
25. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection.
Ronit A; Salem M; Hartling HJ; Gaardbo JC; Ullum H; Gerstoft J; Nielsen SD
APMIS; 2013 May; 121(5):437-46. PubMed ID: 23083518
[TBL] [Abstract][Full Text] [Related]
27. Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
Chen A; Ahlén G; Brenndörfer ED; Brass A; Holmström F; Chen M; Söderholm J; Milich DR; Frelin L; Sällberg M
J Immunol; 2011 May; 186(9):5107-18. PubMed ID: 21430225
[TBL] [Abstract][Full Text] [Related]
28. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
[TBL] [Abstract][Full Text] [Related]
29. Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.
Knödler A; Schmidt SM; Bringmann A; Weck MM; Brauer KM; Holderried TA; Heine AK; Grünebach F; Brossart P
Leukemia; 2009 Mar; 23(3):535-44. PubMed ID: 19005481
[TBL] [Abstract][Full Text] [Related]
30. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
31. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
Shehata MA; Abou El-Enein A; El-Sharnouby GA
Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
[TBL] [Abstract][Full Text] [Related]
32. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.
Dolganiuc A; Norkina O; Kodys K; Catalano D; Bakis G; Marshall C; Mandrekar P; Szabo G
Gastroenterology; 2007 Nov; 133(5):1627-36. PubMed ID: 17916356
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF
J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
36. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2.
Crellin NK; Trifari S; Kaplan CD; Satoh-Takayama N; Di Santo JP; Spits H
Immunity; 2010 Nov; 33(5):752-64. PubMed ID: 21055975
[TBL] [Abstract][Full Text] [Related]
37. HCV core and NS3 proteins mediate toll like receptor induced innate immune response in corneal epithelium.
Rajalakshmy AR; Malathi J; Madhavan HN
Exp Eye Res; 2014 Nov; 128():117-28. PubMed ID: 25280963
[TBL] [Abstract][Full Text] [Related]
38. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.
Brown RA; Gralewski JH; Eid AJ; Knoll BM; Finberg RW; Razonable RR
Transplantation; 2010 Apr; 89(7):811-5. PubMed ID: 20090572
[TBL] [Abstract][Full Text] [Related]
39. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
Díaz-Valdés N; Manterola L; Belsúe V; Riezu-Boj JI; Larrea E; Echeverria I; Llópiz D; López-Sagaseta J; Lerat H; Pawlotsky JM; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
Hepatology; 2011 Jan; 53(1):23-31. PubMed ID: 21154952
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7.
Zhang YL; Guo YJ; Bin Li ; Sun SH
J Hepatol; 2009 Jul; 51(1):29-38. PubMed ID: 19443072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
